Literature DB >> 34635905

Multi-functional polymeric micelles for chemotherapy-based combined cancer therapy.

Raut Bholakant1, Bin Dong1, Xiang Zhou1, Xin Huang1, Changshun Zhao1, Dechun Huang1, Yinan Zhong1, Hongliang Qian1, Wei Chen1, Jan Feijen2.   

Abstract

Currently, the therapeutic performance of traditional mono-chemotherapy on cancers remains unsatisfactory because of the tumor heterogeneity and multidrug resistance. In light of intricate tumor structures and distinct tumor microenvironments (TMEs), combinational therapeutic strategies with multiple anticancer drugs from different mechanisms can synergistically optimize the outcomes and concomitantly minimize the adverse effects during the therapy process. Extensive research on polymeric micelles (PMs) for biomedical applications has revealed the growing importance of nanomedicines for cancer therapy in the recent decade. Starting from traditional simple delivery systems, PMs have been extended to multi-faceted therapeutic strategies. Here we review and summarize the most recent advances in combinational therapy based on multifunctional PMs including a combination of multiple anticancer drugs, chemo-gene therapy, chemo-phototherapy and chemo-immunotherapy. The design approaches, action mechanisms and therapeutic applications of these nanodrugs are summarized. In addition, we highlight the opportunities and potential challenges associated with this promising field, which will provide new guidelines for advanced combinational cancer chemotherapy.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34635905     DOI: 10.1039/d1tb01771c

Source DB:  PubMed          Journal:  J Mater Chem B        ISSN: 2050-750X            Impact factor:   6.331


  2 in total

Review 1.  Micelles as potential drug delivery systems for colorectal cancer treatment.

Authors:  Zaynab Fatfat; Maamoun Fatfat; Hala Gali-Muhtasib
Journal:  World J Gastroenterol       Date:  2022-07-07       Impact factor: 5.374

2.  Prognostic Signature, Immune Features, and Therapeutic Responses of a Novel Ubiquitination-Related Gene Signature in Lung Adenocarcinoma.

Authors:  Muge Xu; Jiening Gong
Journal:  J Oncol       Date:  2022-08-16       Impact factor: 4.501

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.